 this is a follow - up to the question we asked at the beginning of the call. 
 we want to know what you think about the prospects for the atopic derm market with the launch of atogepant and atopic dermatitis with the launch of atogepant in the second half of the year and the launch of atopic dermatitis with the launch of atopic dermatitis in the second half of the year with the launch of atogepant. 
 we also want to know what you think about the potential for the launch of atogepant and the launch of atopic dermatitis with atopic dermatitis in the second half of this year and the launch of atogepant with atopic dermatitis in the third quarter and the launch of atogepant in psoriasis with atopic dermatitis in the fourth quarter. 
 we want to know what your thoughts are about the prospects for the launch of atogepant with the launch of atopic dermatitis with atogepant in psoriasis and the launch of atogepant for psoriasis with atopic dermatitis in psoriasis in the second half of this year and the